Vaccine: Robert Generic addresses the government’s ‘priority’

The United Kingdom was one of the hardest-hit countries in the world after the outbreak of the deadly virus. The number of injuries exceeded two million, and deaths reached a staggering 69,051. Last weekend, the government revealed the emergence of a more virulent strain of the virus across London and Kent.

It is known that the new strain of the virus is spreading 70% faster than the original strain.

But now, data from the Center for Mathematical Modeling of Infectious Diseases has found that the new strain is 56 percent more transmissible than “preexisting variants.”

The study, which has not yet been peer-reviewed, said: “We were unable to find clear evidence that VOC 20 2012/01 results in greater or lesser severity than the pre-existing variants.

However, the increase in transmissibility is likely to lead to a significant increase in incidence, with hospitals and COVID-19 deaths entering higher levels in 2021 than observed in 2020, even if the tiered regional restrictions implemented before December 19 are maintained. .

The government urged to speed up the vaccine (Image: Getty)

Boris Johnson urged to speed up the vaccine

Boris Johnson urged speeding up the vaccine (Image: Getty)

“Our estimates indicate that control measures as stringent as the national lockdown in place in England in November 2020 is unlikely to reduce the effective reproduction number Rt to less than 1, unless primary and secondary schools and universities are also closed.”

They went on to explain how they expected a “big resurgence” of the virus, and urged “speeding up the vaccine.”

The report added: “We expect a major resurgence of the virus after the easing of control measures.

“It may be necessary to expedite the launch of the vaccine in order to have a tangible effect in overcoming the resulting disease burden.”

Read more: The Covid strain appeared in Kent – experts don’t know if a vaccine will work

READ  SpaceX rarely makes landfall; Falcon 9, its first California launch in a year and a half

Professor Chris Whitty

Professor Chris Whitty (Photo: Reuters)

The UK is currently rolling out the Pfizer vaccine and so far more than half a million doses have been administered to patients.

Yesterday, Professor David Salisbury, former director of immunization, urged the government to use current doses on as many high-risk groups as possible.

He told the BBC: “I’ll tell people [that if we did this] We will save more lives.

“I was seeing my Pfizer vaccine with much more power that I inoculate as many people as possible with a single dose, and quickly I had a supply of that.

do not miss
The Minister of Health said that the Oxford vaccine could be launched next month [COMMENT]

Rishi Sunak faces tough decisions as public debt reaches record levels [REVEAL]
Joe Biden takes Pfizer jab LIVE on TV in battle against Coronavirus [INSIGHT]

Set Coronavirus Cases in UK

Set Coronavirus Cases in UK (Image: Express)

“And this, I think in the current circumstances, is really important that I think carefully.”

A spokesperson for the Department of Health and Welfare said: “Our wonderful NHS has vaccinated more than half a million people against COVID-19 with the Pfizer / BioNTech vaccine.

“In the coming weeks and months, the vaccination rate will increase as more doses become available and the program continues to expand.”

The Pfizer vaccine requires two doses up to 21 days apart.

The Pfizer vaccine has been rolled out via the NHS

The Pfizer vaccine has been rolled out via the NHS (Image: Getty)

But Stephen Evans, professor of pharmacokinetics at the London School of Hygiene and Tropical Medicine, cautioned that using only a single dose is from a limited amount of data.

He said: This is not a simple question.

“No trials of the Pfizer / BioNTech vaccine using a single dose have been conducted as an intended procedure, so the amount of data on the efficacy of a single dose is limited.

“What is clear is that there is evidence of effectiveness in the short term, and it seems likely that the efficacy will not be significantly reduced.

Obviously, that effectiveness is close to 80 percent to 90 percent and could be a little lower, but it’s still good.

“A legal difficulty is that the Pfizer / BioNTech vaccine license is for two separate 21-day doses and not a single dose.

“If JCVI objects to this mandate, it may create difficulties from a legal standpoint, but this is a pandemic.”